CE Recognition & UKCA Market Access Strategy

Great Britain currently accepts eligible CE-marked medical devices under defined transitional arrangements up to 30 June 2030, while UKCA remains an available conformity route. The appropriate strategy should be determined product by product.

Assess Your CE Recognition / UKCA Strategy

Current Great Britain Strategic Context

Eligible CE-marked devices remain accepted in Great Britain under current transitional arrangements. Devices compliant with EU MDR or EU IVDR may currently be placed on the GB market up to 30 June 2030, while earlier Directive-based devices are subject to their applicable transition limits. The UK has also consulted on longer-term recognition of CE-marked devices.

11 Strategic Assessment Considerations

Current CE certification basis and underlying European Directive or Regulation

Applicable EU legislation (EU MDR 2017/745, EU IVDR 2017/746 or legacy Directives)

Device risk classification and conformity assessment annexes

Validity, surveillance audits and expiry dates of relevant CE certificates

Current Great Britain CE-recognition legal timelines (valid up to 30 June 2030)

Potential future UK regulatory reform and international recognition frameworks

Commercial and tender necessity for direct UKCA marking certification

Availability, capacity and designated scope of suitable UK Approved Bodies

Portfolio-level multi-year transition roadmap and budget allocation

Northern Ireland Protocol implications and CE / UKNI marking interaction

Dual-market packaging, labeling and IFU harmonization strategy

UKCA Certification Support Deliverables

1UK MDR 2002 conformity assessment route determination (Part II, III or IV)

2UK Approved Body involvement assessment and designation scope matching

3Technical documentation gap analysis against UK essential requirements

4ISO 13485 Quality Management System readiness for UK Approved Body audit

5UK Declaration of Conformity (DoC) authoring and legal signing governance

6UKCA and UKRP labeling placement, symbology and packaging artwork design

7Approved Body stage 1 & stage 2 audit preparation and evidence rehearsal

8Transition and portfolio roadmap balancing CE recognition with UKCA rollout

Senior Regulatory Perspective

Defensible and Commercially Resilient Access

The decision is not "CE or UKCA?" in isolation. The real question is which route provides the most defensible and commercially resilient path for the product portfolio while maintaining simultaneous access to Great Britain, Northern Ireland and global markets.

Key Milestones

Up to 30 June 2030: EU MDR & IVDR CE-marked devices permitted on GB market

Northern Ireland: EU MDR/IVDR applies directly with CE or CE+UKNI

Direct UKCA: Optional now, mandatory when CE transition lapses

Define Your Pathway

Evaluate whether CE recognition or UKCA certification is optimal for your portfolio.

Consult on Pathway

Maximize Market Longevity Across Great Britain and Northern Ireland

Our regulatory strategists balance CE recognition timelines with proactive UKCA certification roadmaps.

Book a Consultation